Fuller & Thaler Asset Management
RIGL icon

Fuller & Thaler Asset Management’s Rigel Pharmaceuticals RIGL Stock Holding History

Fuller & Thaler Asset Management’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-72,387
Closed -$1.35M – 483
2019
Q3 		$1.35M Hold
72,387
– – 0.02% 322
2019
Q2 		$1.89M Sell
72,387
-380
-0.5% -$8.58K 0.02% 295
2019
Q1 		$1.87M Buy
72,767
+2,216
+3% +$50.7K 0.02% 289
2018
Q4 		$1.62M Sell
70,551
-64
-0.1% -$1.81K 0.02% 295
2018
Q3 		$2.27M Buy
+70,615
New +$2.12M 0.02% 296

Other funds holding RIGL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
TA
Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Fuller & Thaler Asset Management's RIGL Position: Q4 2019 in Review

Fuller & Thaler Asset Management sold out of Rigel Pharmaceuticals (RIGL) in Q4 2019, closing a stake of 72,387 shares — an estimated $1.35M sold.

Fuller & Thaler Asset Management first reported a position in RIGL in Q3 2018 and held it in 5 quarters. The position peaked at $2.27M in Q3 2018. 136 funds tracked by Wall St. Rank hold RIGL as of Q4 2019.

  • Fuller & Thaler Asset Management reported no remaining Rigel Pharmaceuticals position as of Q4 2019 after selling out during the quarter.
  • Fuller & Thaler Asset Management sold 72,387 Rigel Pharmaceuticals shares in Q4 2019, an estimated $1.35M.
  • Fuller & Thaler Asset Management first reported a position in Rigel Pharmaceuticals in Q3 2018 and held it in 5 quarters.
  • Fuller & Thaler Asset Management's Rigel Pharmaceuticals position peaked at $2.27M in Q3 2018.
  • 136 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q4 2019.

Based on Fuller & Thaler Asset Management's 13F filing for Q4 2019, filed 14 Feb 2020.